Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 5 min ago
PreprintAll rights reservedmedRxiv

Evaluation of the Efficacy and Safety of Combination Therapy of Vamha and Myrha in the Management of PMOS: An Open-Label, Randomized, Multicentre, Comparative, Prospective Clinical Study

  • A. Patil
  • R. Barathe
  • D. M. Tate
  • K. Kate1
  • S. Pande
  • N. Gawande
  • A. More
  • S. Mahadik
  • K. Berde
  • R. Singhvi
  1. 1Ayurveda Seva Sangh Ayurved Mahavidyalaya, Panchvati, Nashik, Maharashtra, India.
Read full textPDFDOICite

Versions

Related

  1. An explainable artificial intelligence system for prognostic assessment and decision support in diabetic foot ulcer care: a multicentre derivation and validation study with prospective randomised evaluation
    Jia-Yu Zhang, Yangyang Zhuang, Qingping Cao +9
    eClinicalMedicinePeer-reviewedCC BY-NC-ND 4.0General medicineCrossref
  2. Evaluation of percutaneous cryoneurotomy compared with surgical open neurotomy for the management of post-stroke spastic equinovarus foot in France: protocol for a multicentre, randomised controlled, open-label, non-inferiority trial
    Romain David, Maxime Billot, Amine Ounajim +35
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textNeurologyHALCrossref
  3. Radiotherapy dose escalation for the non-operative management of patients with unresectable locally recurrent rectal cancer (STEP-UP): Study protocol for a multicentre, prospective, open-label feasibility study.
    F E C Vande Kerckhove, J L Beeftink, R H N Tijssen +19
    Clinical and translational radiation oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction – a feasibility, safety, and pharmacokinetic study
    Yong Xiang Gwee, Andrea Li Ann Wong, Boon Cher Goh +16
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  5. Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study
    Yamini Kumar, Bala Venkat Subramanian, G V Deepthi +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{patil2026evaluation,
  title = {{Evaluation of the Efficacy and Safety of Combination Therapy of Vamha and Myrha in the Management of PMOS: An Open-Label, Randomized, Multicentre, Comparative, Prospective Clinical Study}},
  author = {A. Patil and R. Barathe and D. M. Tate and K. Kate and S. Pande and N. Gawande and A. More and S. Mahadik and K. Berde and R. Singhvi},
  howpublished = {medRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.20.26360875},
  url = {https://www.medrxiv.org/content/10.64898/2026.08.20.26360875v1},
}
RIS
TY  - UNPB
TI  - Evaluation of the Efficacy and Safety of Combination Therapy of Vamha and Myrha in the Management of PMOS: An Open-Label, Randomized, Multicentre, Comparative, Prospective Clinical Study
AU  - A. Patil
AU  - R. Barathe
AU  - D. M. Tate
AU  - K. Kate
AU  - S. Pande
AU  - N. Gawande
AU  - A. More
AU  - S. Mahadik
AU  - K. Berde
AU  - R. Singhvi
PY  - 2026
DA  - 2026/08/20
PB  - medRxiv
DO  - 10.64898/2026.08.20.26360875
UR  - https://www.medrxiv.org/content/10.64898/2026.08.20.26360875v1
ER  -